SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences informs about newspaper publication

18 Jan 2019 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Camlin Fine Sciences has informed about submission of notice published in the Newspapers viz.- Financial Express (in English) and Loksatta (in Marathi), informing that a meeting of the Board of Directors of the company is scheduled to be held on Friday, February 08, 2019, to consider, take on record and approve the standalone and consolidated unaudited financial results for the quarter ended December 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Camlin Fine Sciences Share Price

136.35 0.25 (0.18%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3867.35
Tata Chemicals 804.70
SRF 2771.90
Pidilite Inds. 1451.20
Deepak Nitrite 1854.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×